1361110-63-5 Usage
Uses
Used in Organic Synthesis:
4-(2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine is used as a reagent in organic synthesis for its ability to act as a boron source, facilitating the formation of carbon-carbon and carbon-nitrogen bonds. This property makes it a valuable component in various chemical reactions.
Used in Pharmaceutical Production:
In the pharmaceutical industry, 4-(2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine is used as an intermediate in the synthesis of various drugs. Its unique structure and reactivity contribute to the development of new pharmaceutical compounds with potential therapeutic applications.
Used in Agrochemical Production:
Similarly, in the agrochemical industry, 4-(2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine serves as an intermediate in the synthesis of agrochemicals. Its versatility in organic synthesis reactions allows for the creation of new compounds with potential applications in agriculture, such as pesticides and herbicides.
Overall, 4-(2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine's importance in the field of organic chemistry and chemical synthesis stems from its versatility and usefulness in a wide range of reactions, making it a valuable asset in both pharmaceutical and agrochemical development.
Check Digit Verification of cas no
The CAS Registry Mumber 1361110-63-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,6,1,1,1 and 0 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1361110-63:
(9*1)+(8*3)+(7*6)+(6*1)+(5*1)+(4*1)+(3*0)+(2*6)+(1*3)=105
105 % 10 = 5
So 1361110-63-5 is a valid CAS Registry Number.
1361110-63-5Relevant academic research and scientific papers
NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES
-
Page/Page column 127; 128, (2012/11/14)
The present invention provides PI3K protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them.
NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES
-
Page/Page column 112-113, (2012/12/13)
The present invention provides PI3K protein kinase modulators, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of kinase mediated diseases or disorders with them.
Imidazo[1,2-a]pyridines: Orally active positive allosteric modulators of the metabotropic glutamate 2 receptor
Trabanco, Andrés A.,Tresadern, Gary,MacDonald, Gregor J.,Vega, Juan Antonio,De Lucas, Ana Isabel,Matesanz, Encarnación,García, Aránzazu,Linares, María Lourdes,Alonso De Diego, Sergio A.,Alonso, José Manuel,Oehlrich, Daniel,Ahnaou, Abdelah,Drinkenburg, Wilhelmus,MacKie, Claire,Andrés, José Ignacio,Lavreysen, Hilde,Cid, José María
experimental part, p. 2688 - 2701 (2012/06/01)
Advanced leads of an imidazopyridine series of positive allosteric modulators of the metabotropic glutamate 2 (mGlu2) receptor are reported. The optimization of in vitro ADMET and in vivo pharmacokinetic properties led to the identification of 27o. With g
